Research ExplorerPublicationsQuality of life and sexual function in patients with borderl...

Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study

Standard

Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study. / Farthmann, Juliane; Hasenburg, Annette; Weil, Meike; Fotopoulou, Christina; Ewald-Riegler, Nina; du Bois, Oya; Trillsch, Fabian; Mahner, Sven; Strauss, Hans-Georg; Wimberger, Pauline; Reuss, Alexander; du Bois, Andreas.

In: SUPPORT CARE CANCER, Vol. 23, No. 1, 01.01.2015, p. 117-23.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Farthmann, J, Hasenburg, A, Weil, M, Fotopoulou, C, Ewald-Riegler, N, du Bois, O, Trillsch, F, Mahner, S, Strauss, H-G, Wimberger, P, Reuss, A & du Bois, A 2015, 'Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study', SUPPORT CARE CANCER, vol. 23, no. 1, pp. 117-23. https://doi.org/10.1007/s00520-014-2330-0

APA

Farthmann, J., Hasenburg, A., Weil, M., Fotopoulou, C., Ewald-Riegler, N., du Bois, O., Trillsch, F., Mahner, S., Strauss, H-G., Wimberger, P., Reuss, A., & du Bois, A. (2015). Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study. SUPPORT CARE CANCER, 23(1), 117-23. https://doi.org/10.1007/s00520-014-2330-0

Vancouver

Farthmann J, Hasenburg A, Weil M, Fotopoulou C, Ewald-Riegler N, du Bois O et al. Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study. SUPPORT CARE CANCER. 2015 Jan 1;23(1):117-23. https://doi.org/10.1007/s00520-014-2330-0

Bibtex

@article{e5e8e43a973845febf496bc0b99624d1,
title = "Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study",
abstract = "PURPOSE: Borderline tumors of the ovary (BOT) represent an entity of ovarian neoplasms with low malignant potential and excellent prognosis. Mainstay of therapy is surgery including adequate staging and complete tumor resection, possibly inducing long-term side effects, especially in premenopausal women. The aim of this study was to evaluate quality of life (QoL) and sexual function in patients treated for BOT, also with respect to treatment modalities.METHODS: This prospective study was part of an ambidirectional multicentric cohort study in patients with BOT in Germany. Patients from seven centers completed three questionnaires after completion of therapy. QoL and sexual function data were correlated with treatment characteristics: surgical approach, lymphadenectomy, and fertility sparing surgery.RESULTS: One hundred ten patients returned the questionnaires. Median follow-up was 4.0 years. The majority lived in a relationship (n = 85, 77%, missing n = 4), and 49% (n = 54, missing n = 6) were sexually active. The main reason for sexual inactivity was {"}no partner{"} (38%). The women had a mean global health status of 69.8 (SD 22.7; min 0, max 100), with 100 implying perfect health. Mean QoL score was 73.7 (SD 23.3, range 0 to 100). Both scores showed no difference regarding fertility preserving surgery, surgical approach, and lymphadenectomy. Sexually active women had a significantly higher QoL (78.7 vs. 67.4, p = 0.0156) and global health status (75.9 vs. 60.9, p = 0.0013) than inactive patients.CONCLUSIONS: In this prospective study, patients who had been diagnosed with BOT had a very good quality of life and global health status. Sexually inactive women stated lack of a partner as the main reason and had an inferior HRQoL compared to sexually active women.",
author = "Juliane Farthmann and Annette Hasenburg and Meike Weil and Christina Fotopoulou and Nina Ewald-Riegler and {du Bois}, Oya and Fabian Trillsch and Sven Mahner and Hans-Georg Strauss and Pauline Wimberger and Alexander Reuss and {du Bois}, Andreas",
year = "2015",
month = jan,
day = "1",
doi = "10.1007/s00520-014-2330-0",
language = "English",
volume = "23",
pages = "117--23",
journal = "SUPPORT CARE CANCER",
issn = "0941-4355",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study

AU - Farthmann, Juliane

AU - Hasenburg, Annette

AU - Weil, Meike

AU - Fotopoulou, Christina

AU - Ewald-Riegler, Nina

AU - du Bois, Oya

AU - Trillsch, Fabian

AU - Mahner, Sven

AU - Strauss, Hans-Georg

AU - Wimberger, Pauline

AU - Reuss, Alexander

AU - du Bois, Andreas

PY - 2015/1/1

Y1 - 2015/1/1

N2 - PURPOSE: Borderline tumors of the ovary (BOT) represent an entity of ovarian neoplasms with low malignant potential and excellent prognosis. Mainstay of therapy is surgery including adequate staging and complete tumor resection, possibly inducing long-term side effects, especially in premenopausal women. The aim of this study was to evaluate quality of life (QoL) and sexual function in patients treated for BOT, also with respect to treatment modalities.METHODS: This prospective study was part of an ambidirectional multicentric cohort study in patients with BOT in Germany. Patients from seven centers completed three questionnaires after completion of therapy. QoL and sexual function data were correlated with treatment characteristics: surgical approach, lymphadenectomy, and fertility sparing surgery.RESULTS: One hundred ten patients returned the questionnaires. Median follow-up was 4.0 years. The majority lived in a relationship (n = 85, 77%, missing n = 4), and 49% (n = 54, missing n = 6) were sexually active. The main reason for sexual inactivity was "no partner" (38%). The women had a mean global health status of 69.8 (SD 22.7; min 0, max 100), with 100 implying perfect health. Mean QoL score was 73.7 (SD 23.3, range 0 to 100). Both scores showed no difference regarding fertility preserving surgery, surgical approach, and lymphadenectomy. Sexually active women had a significantly higher QoL (78.7 vs. 67.4, p = 0.0156) and global health status (75.9 vs. 60.9, p = 0.0013) than inactive patients.CONCLUSIONS: In this prospective study, patients who had been diagnosed with BOT had a very good quality of life and global health status. Sexually inactive women stated lack of a partner as the main reason and had an inferior HRQoL compared to sexually active women.

AB - PURPOSE: Borderline tumors of the ovary (BOT) represent an entity of ovarian neoplasms with low malignant potential and excellent prognosis. Mainstay of therapy is surgery including adequate staging and complete tumor resection, possibly inducing long-term side effects, especially in premenopausal women. The aim of this study was to evaluate quality of life (QoL) and sexual function in patients treated for BOT, also with respect to treatment modalities.METHODS: This prospective study was part of an ambidirectional multicentric cohort study in patients with BOT in Germany. Patients from seven centers completed three questionnaires after completion of therapy. QoL and sexual function data were correlated with treatment characteristics: surgical approach, lymphadenectomy, and fertility sparing surgery.RESULTS: One hundred ten patients returned the questionnaires. Median follow-up was 4.0 years. The majority lived in a relationship (n = 85, 77%, missing n = 4), and 49% (n = 54, missing n = 6) were sexually active. The main reason for sexual inactivity was "no partner" (38%). The women had a mean global health status of 69.8 (SD 22.7; min 0, max 100), with 100 implying perfect health. Mean QoL score was 73.7 (SD 23.3, range 0 to 100). Both scores showed no difference regarding fertility preserving surgery, surgical approach, and lymphadenectomy. Sexually active women had a significantly higher QoL (78.7 vs. 67.4, p = 0.0156) and global health status (75.9 vs. 60.9, p = 0.0013) than inactive patients.CONCLUSIONS: In this prospective study, patients who had been diagnosed with BOT had a very good quality of life and global health status. Sexually inactive women stated lack of a partner as the main reason and had an inferior HRQoL compared to sexually active women.

U2 - 10.1007/s00520-014-2330-0

DO - 10.1007/s00520-014-2330-0

M3 - SCORING: Journal article

C2 - 24996831

VL - 23

SP - 117

EP - 123

JO - SUPPORT CARE CANCER

JF - SUPPORT CARE CANCER

SN - 0941-4355

IS - 1

ER -